Pictet & Cie Europe Sa Lowered By $585,369 Its Waters (WAT) Holding; Shorts at STE VIRBAC SA ORDINARY SHARES (VRBCF) Raised By 0.61%

April 19, 2018 - By Ellis Scott

Waters Corporation (NYSE:WAT) Logo

Pictet & Cie Europe Sa decreased Waters Corp (WAT) stake by 55.15% reported in 2017Q4 SEC filing. Pictet & Cie Europe Sa sold 3,033 shares as Waters Corp (WAT)’s stock rose 3.47%. The Pictet & Cie Europe Sa holds 2,467 shares with $477,000 value, down from 5,500 last quarter. Waters Corp now has $16.45 billion valuation. The stock increased 1.18% or $2.45 during the last trading session, reaching $210.05. About 342,406 shares traded. Waters Corporation (NYSE:WAT) has risen 28.61% since April 19, 2017 and is uptrending. It has outperformed by 17.06% the S&P500.

STE VIRBAC SA ORDINARY SHARES (OTCMKTS:VRBCF) had an increase of 0.61% in short interest. VRBCF’s SI was 16,400 shares in April as released by FINRA. Its up 0.61% from 16,300 shares previously. With 100 avg volume, 164 days are for STE VIRBAC SA ORDINARY SHARES (OTCMKTS:VRBCF)’s short sellers to cover VRBCF’s short positions. It closed at $142 lastly. It is down 0.00% since April 19, 2017 and is . It has underperformed by 11.55% the S&P500.

Virbac SA produces and sells medicines and vaccines for companion and food-producing animals. The company has market cap of $1.27 billion. The firm offers Activyl, Activyl Tick Plus, and Effipro duo solutions to treat and prevent flea infestations; Biomox, an oral antibiotic; Bovigen scour, a vaccine to reduce diarrhea; Canigen, a vaccines range for canine distemper, hepatitis, rabies, parvovirus, para-influenza, and leptospirosis; Cortavance, a spray for inflammatory dermatosis; Curacef duo to treat respiratory diseases; Cyclavance to treat atopic dermatitis; and Easotic to treat otitis. It currently has negative earnings. It also provides Effitix to treat tick, flea, and mosquito infestations; Epiotic, an ear cleanser; Euthasol, a euthanasic injectable solution; Inflacalm, an anti-inflammatory; Iverhart, a chewable tablet to prevent heartworm disease, as well as treat and control roundworms, hookworms, and tapeworms; Leucogen, a vaccine against feline leukaemia; Milpro, an internal parasiticide tablet; Movoflex, a soft chew for joint support; Multibio, a product to treat digestive, respiratory, and genito-urinary diseases; and Multimin, a trace element injectable supplement.

Analysts await Waters Corporation (NYSE:WAT) to report earnings on April, 24 before the open. They expect $1.55 EPS, up 6.16% or $0.09 from last year’s $1.46 per share. WAT’s profit will be $121.36 million for 33.88 P/E if the $1.55 EPS becomes a reality. After $2.51 actual EPS reported by Waters Corporation for the previous quarter, Wall Street now forecasts -38.25% negative EPS growth.

Among 19 analysts covering Waters Corporation (NYSE:WAT), 7 have Buy rating, 0 Sell and 12 Hold. Therefore 37% are positive. Waters Corporation had 57 analyst reports since July 29, 2015 according to SRatingsIntel. The rating was maintained by Barclays Capital on Wednesday, July 27 with “Equalweight”. The rating was maintained by Morgan Stanley on Friday, October 6 with “Underweight”. Cowen & Co maintained the shares of WAT in report on Tuesday, January 23 with “Hold” rating. Citigroup maintained Waters Corporation (NYSE:WAT) rating on Wednesday, July 27. Citigroup has “Neutral” rating and $160 target. Mizuho maintained the stock with “Neutral” rating in Wednesday, July 29 report. Robert W. Baird maintained the shares of WAT in report on Wednesday, January 24 with “Outperform” rating. The firm earned “Buy” rating on Wednesday, April 26 by Cantor Fitzgerald. Jefferies maintained the stock with “Hold” rating in Tuesday, June 6 report. The firm earned “Buy” rating on Tuesday, October 25 by Cantor Fitzgerald. The rating was maintained by Barclays Capital on Wednesday, October 25 with “Equal-Weight”.

Since October 27, 2017, it had 0 insider buys, and 12 sales for $39.83 million activity. Khanna Rohit sold 26,913 shares worth $5.33M. Cassis Eugene G had sold 23,863 shares worth $4.71 million. BEAUDOUIN MARK T also sold $9.15M worth of Waters Corporation (NYSE:WAT) on Thursday, January 25. $318,002 worth of stock was sold by TERRICCIANO DAVID on Wednesday, February 28. Kelly Terrence P sold $278,826 worth of Waters Corporation (NYSE:WAT) on Friday, March 9. Shares for $1.48 million were sold by KUEBLER CHRISTOPHER A. Shares for $6.22M were sold by Rae Elizabeth B on Monday, January 29.

Pictet & Cie Europe Sa increased Cintas Corp (NASDAQ:CTAS) stake by 3,000 shares to 9,800 valued at $1.53 million in 2017Q4. It also upped United Technologies Corp (NYSE:UTX) stake by 22,050 shares and now owns 102,598 shares. Spdr S&P 500 Etf Tr (SPY) was raised too.

Investors sentiment increased to 1.13 in Q4 2017. Its up 0.14, from 0.99 in 2017Q3. It is positive, as 24 investors sold WAT shares while 171 reduced holdings. 61 funds opened positions while 159 raised stakes. 72.10 million shares or 2.19% less from 73.71 million shares in 2017Q3 were reported. Gam Ag, Switzerland-based fund reported 11,372 shares. Smith Asset Management Group LP accumulated 137,420 shares. New York-based Blackrock Inc has invested 0.05% in Waters Corporation (NYSE:WAT). Castleark Management Lc invested 0.04% in Waters Corporation (NYSE:WAT). Ameritas Invest Partners Inc holds 1,722 shares or 0.02% of its portfolio. Blair William & Il, Illinois-based fund reported 5,771 shares. The Pennsylvania-based Armstrong Henry H Associate Incorporated has invested 0.45% in Waters Corporation (NYSE:WAT). Everence Management holds 0.07% or 1,646 shares in its portfolio. Numeric Invsts Ltd has invested 0.01% in Waters Corporation (NYSE:WAT). Holt Capital Advsrs Lc Dba Holt Capital Limited Partnership reported 1,400 shares. Oakworth holds 444 shares or 0.02% of its portfolio. Point72 Asia (Hong Kong) Ltd reported 0.05% in Waters Corporation (NYSE:WAT). Harding Loevner Lp, New Jersey-based fund reported 872,307 shares. State Teachers Retirement System has invested 0.06% of its portfolio in Waters Corporation (NYSE:WAT). Btim has 0.75% invested in Waters Corporation (NYSE:WAT) for 264,407 shares.

Waters Corporation (NYSE:WAT) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>